confex.com rank 12 |
Number of domains linking to confex.com 13 | semantic flow 2.52 |
Number of links to confex.com 32 | semantic flow 2.52 |
Number of domains linked from confex.com 1 | semantic flow 0.08 |
Number of links from confex.com 1 | semantic flow 0.08 |
Pages with highest topical PageRank pointing to domain.
On-topic pages from domain with highest topical PageRank.
title / url | |||||||||
---|---|---|---|---|---|---|---|---|---|
Abstract: Association of T Cell Activation with a Non-invasive Marker of Liver Fibrosis in HIV-infected Women with and without Hepatitis C https://idsa.confex.com/idsa/2013/webprogram/Paper42484.html | 0.28 | 1 | 28 | 9 | 0 | 0 | 0 | 0 | |
Program: Oral Abstract Session (IDWeek 2017) https://idsa.confex.com/idsa/2017/webprogram/ORAL.html | 0.28 | 1 | 66 | 11 | 1 | 1 | 0 | 0 | |
Abstract: 48-Week Safety and Efficacy On-Treatment Analysis of Ibalizumab in Patients with Multi-Drug Resistant HIV-1 (IDWeek https://idsa.confex.com/idsa/2017/webprogram/Paper66828.html | 0.28 | 0.89 | 37 | 5 | 1 | 1 | 1 | 1 | |
Session: HIV: Treatment, Complications, and Outcomes (IDWeek 2013) https://idsa.confex.com/idsa/2013/webprogram/Session5737.html | 0.28 | 1 | 33 | 11 | 0 | 0 | 0 | 0 | |
Abstract: IDSA Maintenance of Certification: Self-Evaluation of Medical Knowledge Modules: HIV 2013 and Hepatitis C (IDWeek https://idsa.confex.com/idsa/2013/webprogram/Paper39272.html | 0.28 | 1 | 28 | 9 | 0 | 0 | 0 | 0 | |
Abstract: IDSA Maintenance of Certification Workshop: Self-Evaluation of Medical Knowledge Modules: General Infectious Diseases 2011 https://idsa.confex.com/idsa/2013/webprogram/Paper39270.html | 0.28 | 1 | 28 | 9 | 0 | 0 | 0 | 0 | |
Abstract: Barriers to Hepatitis C Treatment in HIV co-infected Patients in the Era of new Direct-Acting Antiviral Therapy (IDWeek https://idsa.confex.com/idsa/2017/webprogram/Paper65648.html | 0.21 | 1 | 38 | 5 | 1 | 1 | 1 | 1 | |
Session: HIV: Comorbidities and Coinfections (IDWeek 2014) https://idsa.confex.com/idsa/2014/webprogram/Session6669.html | 0.21 | 1 | 78 | 35 | 0 | 0 | 0 | 0 | |
Program: Poster Abstract Session (IDWeek 2014) https://idsa.confex.com/idsa/2014/webprogram/POSTER.html | 0.21 | 1 | 95 | 18 | 0 | 0 | 0 | 0 | |
Abstract: Primary Efficacy Endpoint and Safety Results of Ibalizumab (IBA) in a Phase 3 Study of Heavily Treatment-Experienced Patients https://idsa.confex.com/idsa/2016/webprogram/Paper60965.html | 0.21 | 0.97 | 37 | 3 | 1 | 1 | 1 | 1 |
Relevant domains with most links to selected domain.
Relevant domains with most links from selected domain.
domain | |||
---|---|---|---|
http://idweek.org/ | 1 | 0.08 | idweek.org |
Pages from domain with most relevant inbound links.
url | |||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
https://idsa.confex.com/idsa/2017/webprogram/Paper66702.html | 1 | 0.17 | 0.99 | 0.09 | 0.99 | yes | 38 | 5 | 1 | 1 | 1 | 1 | |
https://idsa.confex.com/idsa/2017/webprogram/Handout/id5815/POSTER063_564.pdf | 1 | 0.17 | 1 | 0.08 | -1 | - | -1 | -1 | -1 | -1 | 1 | 1 | |
https://idsa.confex.com/idsa/2013/webprogram/ORAL.html | 1 | 0.16 | 1 | 0.08 | 1 | yes | 59 | 15 | 0 | 0 | 0 | 0 | |
https://idsa.confex.com/idsa/2013/webprogram/Paper40032.html | 1 | 0.16 | 1 | 0.08 | 0.99 | yes | 28 | 9 | 0 | 0 | 1 | 1 | |
https://idsa.confex.com/idsa/2013/webprogram/Paper39868.html | 1 | 0.16 | 0.99 | 0.08 | 1 | yes | 29 | 9 | 0 | 0 | 1 | 1 | |
https://idsa.confex.com/idsa/2013/webprogram/Paper40335.html | 1 | 0.16 | 0.99 | 0.08 | 1 | yes | 29 | 9 | 0 | 0 | 1 | 1 | |
https://idsa.confex.com/idsa/2013/webprogram/Paper42415.html | 1 | 0.16 | 0.99 | 0.08 | 1 | yes | 29 | 9 | 0 | 0 | 1 | 1 | |
https://idsa.confex.com/idsa/2013/webprogram/Paper41842.html | 1 | 0.16 | 0.99 | 0.08 | 1 | yes | 29 | 9 | 0 | 0 | 1 | 1 | |
https://idsa.confex.com/idsa/2017/webprogram/Paper66284.html | 1 | 0.18 | 0.99 | 0.07 | 1 | yes | 37 | 5 | 1 | 1 | 1 | 1 | |
https://idsa.confex.com/idsa/2016/webprogram/Paper58740.html | 1 | 0.15 | 0.9 | 0.06 | -1 | - | -1 | -1 | -1 | -1 | 1 | 1 |
Pages from domain with most likely on-topic outgoing links.
url | |||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
https://idsa.confex.com/idsa/2013/webprogram/authora.html | 75 | 0.16 | 1 | 3.68 | 1 | yes | 381 | 85 | 0 | 0 | 0 | 0 | |
https://idsa.confex.com/idsa/2017/webprogram/track8735.html | 40 | 0.18 | 0.99 | 3.19 | 1 | yes | 109 | 44 | 1 | 1 | 0 | 0 | |
https://idsa.confex.com/idsa/2013/webprogram/track3264.html | 29 | 0.16 | 1 | 2 | 1 | yes | 96 | 38 | 0 | 0 | 0 | 0 | |
https://idsa.confex.com/idsa/2017/webprogram/POSTER.html | 10 | 0.18 | 0.98 | 0.47 | 1 | yes | 135 | 33 | 1 | 1 | 0 | 0 | |
https://idsa.confex.com/idsa/2013/webprogram/Paper39868.html | 9 | 0.16 | 0.99 | 0.74 | 1 | yes | 29 | 9 | 0 | 0 | 1 | 1 | |
https://idsa.confex.com/idsa/2017/webprogram/Paper66702.html | 5 | 0.17 | 0.99 | 0.39 | 0.99 | yes | 38 | 5 | 1 | 1 | 1 | 1 | |
https://idsa.confex.com/idsa/2013/webprogram/Session5750.html | 4 | 0.16 | 1 | 0.32 | 1 | yes | 34 | 13 | 0 | 0 | 0 | 0 | |
https://idsa.confex.com/idsa/2013/webprogram/ORAL.html | 3 | 0.16 | 1 | 0.15 | 1 | yes | 59 | 15 | 0 | 0 | 0 | 0 | |
https://idsa.confex.com/idsa/2017/webprogram/Paper64144.html | 1 | 0.19 | 0.99 | 0.09 | 1 | yes | 38 | 6 | 1 | 1 | 1 | 1 | |
https://idsa.confex.com/idsa/2013/webprogram/Paper40335.html | 1 | 0.16 | 0.99 | 0.08 | 1 | yes | 29 | 9 | 0 | 0 | 1 | 1 |
Similar domains to domain, based on inbound linking patterns from other relevant domains. This is also known in SEO as topical co-citation.